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Expression of Epstein-Barr virus-encoded BamH1–a right-
ward  transcript 7 microRNA in nasopharyngeal carcinoma cells 
 modulates the responsiveness to irradiation treatment
YWJ Chan†, W Gao†, ZHJ Li, W K Ho, TS Wong*†
Abstract 
Introduction
Nasopharyngeal carcinoma is highly 
sensitive to irradiation treatment. 
Expression of Epstein-Barr virus gene 
products affects the radiosensitivity 
of these cancer cells. In this paper, the 
association between the Epstein-Barr 
virus-encoded BamH1–a rightward 
transcript 7 microRNA (ebv-miR-
BART7) and the effects on irradiation 
sensitivity was explored.
Methods
Ebv-miR-BART7 expression level in 
the tissue was quantified using real-
time quantitative polymerase chain 
reaction. The radiosensitivity of 
nasopharyngeal carcinoma cells with 
ebv-miR-BART7 expression was eval-
uated by colony formation assay, cell 
proliferation assay, apoptosis assay, 
H2AX phosphorylation staining and 
acridine orange staining. In addition, 
a xenograft model was developed 
using a zebrafish embryo to validate 
the in vivo radiation sensitivity of the 
ebv-miR-BART7-expressing naso-
pharyngeal carcinoma. 
Results
Primary and recurrent naso-
pharyngeal carcinoma tissues had a 
 significantly higher ebv-miR-BART7 
expression level in comparison with 
their corresponding normal counter-
parts. The ebv-miR-BART7-express-
ing nasopharyngeal carcinoma cells 
had higher sensitivity to irradiation 
treatment. 
Conclusion
Our results suggest that patients 
with nasopharyngeal carcinoma have 
elevated ebv-miR-BART7 expression 
levels in the primary and recurrent 
nasopharyngeal carcinoma tissues. 
Higher expression of ebv-miR-
BART7 increased the sensitivity of 
nasopharyngeal carcinoma cells to 
irradiation treatment. Further inves-
tigation with regard to the clinical 
value of ebv-miR-BART7 to aid ther-
apeutic response is warranted in 
order to evaluate the potential use 
of ebv-miR-BART7 as a molecular 
biomarker in monitoring patients 
with nasopharyngeal carcinoma. 
Introduction 
Nasopharyngeal carcinoma (NPC) 
commonly arises from the pharyn-
geal recess, the fossa of Rosenmüller, 
which is situated medial to the medial 
crus of the Eustachian tube opening 
into the nasal cavity1. This cancer 
can originate from the epithelium 
overlying the lymphoid tissues and 
is also known as lymphoepithelioma 
or lymphoepithelial carcinoma2. 
According to the World Health Organ-
ization classification, NPC can be clas-
sified into the following subtypes: 
squamous cell carcinoma (SCC, type 
1, with different degrees of differ-
entiation) and undifferentiated/
non-keratinising carcinoma (type 2 
and type 3), with variable response 
to therapeutic agents3. In compar-
ison to SCC, early undifferentiated/
non-keratinising carcinoma is more 
sensitive to irradiation treatment, 
and patients show an improved local 
control rate in response to radio-
therapy4. Thus, most of the early NPC 
patients are treated with irradiation-
based therapy5. If the cancers acquire 
resistance during the course of treat-
ment or are intrinsically resistant to 
irradiation treatment, it may lead to 
the development of local recurrence 
and distant metastasis6. At present, 
the reasons or the mechanisms 
leading to the high sensitivity and/
or resistance of NPC to irradiation 
treatment remains unknown. It has 
been suggested that the sensitivity/
resistance of cancer cells to irradia-
tion treatment is affected by different 
apoptotic pathways associated with 
treatment response7. 
Unlike SCC, undifferentiated/non-
keratinising NPC is characterised by 
its close association with the Epstein-
Barr virus (EBV), the first tumour 
virus found in association with 
human malignancies. EBV infection 
is specific to the tumour tissue and is 
absent in the adjacent normal naso-
pharyngeal epithelia. Recently, it was 
found that the EBV could produce a 
group of non-coding RNAs known 
as microRNAs (miRNAs) in the host 
cells8. These small, non-protein-
coding RNAs (single-stranded) func-
tion as gene-specific regulators. 
Mature miRNAs can form a functional 
unit similar to the RNA-induced 
silencing complex used for RNA 
interference in the cytoplasm9. Func-
tionally, miRNAs can regulate protein 
expression at the post-transcrip-
tional level through direct binding to 
specific messenger RNA molecules. 
The specific binding of miRNA mole-
cules can promote degradation of the 
messenger RNA and/or hinder the 
translation process. At present, little 
* Corresponding author
Email:  thiansze@graduate.hku.hk
†  These authors contributed equally to this 
study.
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is known about the functional role 
of the viral miRNA. Expression of the 
viral miRNA is suggested to be associ-
ated with the activity and replication 
of EBV8. In EBV-positive cell lines, high 
expression of EBV miRNA has been 
reported. Mature viral miRNAs can 
be detected in two days after infec-
tion and are regarded as an impor-
tant initiator of the viral life cycle in 
host cells8. In addition, expression of 
the EBV-encoded miRNA can change 
the responsiveness of the NPC cells to 
DNA-damaging agents and modulate 
apoptosis signalling pathways10,11. 
In this paper, we explored the 
potential association between the 
EBV-encoded miRNA (ebv-miR-
BART7) and the responsiveness to 
irradiation treatment. The radiosen-
sitivity of the NPC cells with ebv-miR-
BART7 expression was examined 
with the use of in vitro cell irradia-
tion. In addition, xenograft models 
were developed with the use of 
zebrafish embryos to examine these 
effects in the in vivo setting. 
Materials and methods
Patient samples
Undifferentiated NPC tissue samples 
were obtained from the Depart-
ment of Surgery, The University of 
Hong Kong, Queen Mary Hospital, 
Hong Kong. Written consent of tissue 
donation for research purposes were 
obtained from patients before tissue 
collection. The protocol was approved 
by the Institutional Review Board 
of the hospital (reference number 
UW 10-142). Tissue samples were 
stored in liquid nitrogen for trans-
portation and stored at −70°C until 
used. Tissue samples were collected 
from 42 patients with primary NPC, 
29 with recurrent NPC and 29 non-
cancer volunteers. The 42 patients 
with primary NPC included 32 males 
and 10 females, with age ranging from 
12–75 years. There were 11 patients 
in the T1 stage, 9 in the T2 stage, 18 
Figure 1: Relative ebv-miR-BART7 expression levels in tissue samples from patients with NPC and healthy controls. The relative ex-
pression level of ebv-miR-BART7 was normalised to U6 snRNA by quantitative polymerase chain reaction analysis and the data are 
displayed as 2−ΔCt. (A) Relative ebv-miR-BART7 expression levels in tissue samples from patients with primary NPC, recurrent NPC and 
healthy controls. (B) Relative ebv-miR-BART7 expression levels in paired tumour and normal samples from patients with recurrent 
NPC. NPC, nasopharyngeal carcinoma.
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in the T3 stage and 4 in the T4 stage. 
The 29 patients with recurrent NPC 
included 22 males and 7  females, with 
age ranging from 29–75 years. There 
were 13 patients in the T1 stage, 4 in 
the T2 stage, 9 in the T3 stage and 3 
in the T4 stage. The 29 healthy volun-
teers included 20 males and 9 females, 
with age ranging from 6–81 years.  
Cell line
The NPC cell line HONE1 was 
derived from poorly differentiated 
NPC tissues. The EBV genome in 
the HONE1 cell line was lost after 
prolonged culture and passage12. 
The cell line was maintained in 
an RPMI 1640 medium (Gibco®) 
supplemented with 10% foetal 
bovine serum (Gibco®), 200 unit/ml 
 penicillin G sodium (Gibco®), 200 µg/
ml streptomycin sulphate (Gibco®) 
and 0.5 µg/ml amphotericin B; cells 
were incubated at 37°C in a humidi-
fied incubator under 5% CO
2
.
RNA extraction and real-time quan-
titative polymerase chain reaction 
analysis
Total RNA was extracted with TRIZOL 
(Life Technologies™) following the 
manufacturer’s protocol. The tran-
script levels of ebv-miR-BART7 
(Assay ID: 197206_mat, Life Tech-
nologies™) and U6 small nuclear RNA 
(internal control, assay ID: 001973, 
Life Technologies™) were measured 
by LightCycler® 480 (Roche Applied 
Science) using the comparative cycle 
threshold method. All reactions were 
carried out in triplicate.
Cell irradiation 
Cell irradiation was performed using 
Gammacell® 3000 Elansystem (Best 
Theratronics Ltd.). 
Colony formation assay 
HONE1 was transfected with 3 nM 
ebv-miR-BART7 mimics (Qiagen) or 
negative control small interfering 
RNA (siRNA, Qiagen) using Hiperfect 
transfection reagent (Qiagen). After 
24 hours, the cells were transferred 
to a fresh medium and were irradi-
ated at a single dose of 2, 4, 6 or 8 Gy. 
The irradiated cells were placed in a 
six-well plate (600 cells per well) and 
incubated for 14 days. The cells were 
fixed with 70% ethanol and stained 
with 0.5% crystal violet. Colonies 
consisting of more than 50 cells were 
scored. 
Proliferation assay
Real-time cell proliferation assay was 
performed on E-Plate 16 using the 
RTCA DP instrument (Roche Applied 
Science). HONE1 cells were trans-
fected with 0.75 nM, 1.5 nM or 3 nM 
ebv-miR-BART7 mimics (Qiagen) 
or negative control siRNA (Qiagen) 
using Hiperfect transfection reagent 
(Qiagen). After 24 hours, the trans-
fected cells were transferred to a 
fresh medium and were irradiated at 
a single dose of 8 Gy; the cell prolif-
eration rate was monitored continu-
ously for 63 hours. 
Apoptotic assays
Cell apoptosis was detected by 
Annexin V staining using Cytomics™ 
FC 500 (Beckman Coulter). HONE1 
cells were transfected with 3 nM 
ebv-miR-BART7 mimics (Qiagen) 
or negative control siRNA (Qiagen) 
using Hiperfect transfection reagent 
(Qiagen). Twenty-four hours after 
transfection, the cells were irradi-
ated at a single dose of 2, 4, 6 or 8 Gy. 
The irradiated cells were harvested 
and resuspended in Annexin-binding 
buffer (10 mM HEPES, 140 mM 
NaCl and 2.5 mM CaCl
2
, pH 7.4) and 
stained with fluorescein isothiocy-
anate (FITC)-labelled Annexin V (Life 
Technologies™). 
H2AX phosphorylation
Detection and quantification of 
phosphorylated H2AX (γH2AX) was 
performed according to the published 
protocol13. HONE1 cells were trans-
fected with 3 nM ebv-miR-BART7 
mimics (Qiagen) or negative control 
siRNA (Qiagen) using Hiperfect trans-
fection reagent (Qiagen). Twenty-four 
hours after transfection, the cells 
were irradiated at a single dose of 2, 
4, 6 or 8 Gy. The irradiated cells were 
stained with rabbit polyclonal anti-
γH2AX antibodies (Abcam) and goat 
anti-rabbit immunoglobulin G-FITC 
conjugate (Life Technologies™). DAPI 
(Life Technologies™) and Alexa Fluor® 
635 phalloidin (Life Technologies™) 
were used to stain the nucleus and 
F-actin. The number of γH2AX foci in 
the cells was counted using a fluores-
cent microscope. 
Acridine orange (AO) staining
AO was used to detect cell autophagy 
after cell irradiation. Autophagy is 
characterised by the formation of 
acidic vesicular organelles (AVO). 
The AO-stained AVOs appear red. 
The cytoplasm and nucleolus appear 
as bright green and dim red, respec-
tively14. After irradiation treatment, 
the cells were stained with 1 µg/ml 
Figure 2: Ebv-miR-BART7 reduced 
colony formation ability in HONE1 cells 
after irradiation treatment. HONE1 cells 
were transfected with 3 nM ebv-miR-
BART7 mimics or the negative control. 
After 24 hours, cells were irradiated at 
a single dose of 2, 4, 6 or 8 Gy. Following 
irradiation, cells were plated as 600 cells 
per well in a six-well plate and incubated 
for 14 days. Colonies consisting of more 
than 50 cells were scored. The number of 
colonies of HONE1 cells transfected with 
BART7 mimics was normalised to that of 
HONE1 cells transfected with the nega-
tive control. The assay was performed in 
six-replicate. Bars indicate standard de-
viation, *p < 0.05 and **p < 0.01 by Stu-
dent’s t-test.
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AO (Sigma-Aldrich) and monitored 
using a fluorescent microscope. 
Zebrafi sh NPC xenograft  
 development and irradiation assays
In vivo radiation sensitivity was exam-
ined with the use of a zebrafish model 
according to a previously  published 
protocol15,16. A wild-type zebrafish 
strain was used to develop the NPC 
xenograft. The study was approved 
by the Committee on the Use of Live 
Animals in Teaching and Research 
at The University of Hong Kong 
(CULATR 2939-13). The zebrafish 
was kept at 28.5°C with 14/10 hour 
day–night cycle. The 48-hpf zebrafish 
embryos were anesthetised with 
tricaine (Sigma-Aldrich) before 
microinjection, under a dissecting 
light microscope (SMZ1000, Nikon). 
HONE1 cells transfected with 3 nM 
ebv-miR-BART7 mimics (Qiagen) or 
control siRNA (Qiagen) were stained 
with DiO (Life Technologies™) before 
microinjection. The embryos were 
incubated in the zebrafish E3 embryo 
medium for 24 h before irradiation. 
Irradiation of the zebrafish embryos 
was performed with Gammacell® 
3000 Elansystem (Best Theratronics 
Ltd.). Microscopic inspection was 
performed using an inverted micro-
scope (CKX41, Olympus). The fluo-
rescence signal was quantified using 
ImageJ17. The fluorescence signal of 
HONE1 cells transfected with the 
ebv-miR-BART7 mimics was normal-
ised to that of HONE1 cells trans-
fected with the negative control. 
Statistical analysis
Statistical analysis was performed 
using the SPSS v16.0 (SPSS, Chicago, 
Illinois, USA). Data are expressed 
as mean ± standard deviation. All 
the tests were two-sided. A p value 
of <0.05 was considered statistical 
significant.
Results
Relative ebv-miR-BART7 expression 
level in tissue samples from patients 
with primary NPC, recurrent NPC 
and healthy controls
Ebv-miR-BART7 was detectable in 
all primary (42/42) and recurrent 
NPC tissues (29/29). In normal naso-
pharyngeal tissues, ebv-miR-BART7 
was detected in 28/29 (97%) tissue 
samples. For the paired normal naso-
pharyngeal tissues obtained from 
the recurrent NPC patients, ebv-miR-
BART7 was detected in 28/29 (97%) 
tissue samples.
Figure 3: HONE1 cells transfected with ebv-miR-BART7 mimics exhibited a suppressed proliferation rate in comparison with HONE1 
cells transfected with the negative control upon irradiation exposure. HONE1 cells were transfected with 0.75 nM, 1.5 nM or 3 nM ebv-
miR-BART7 mimics or the negative control. Then, the cells were seeded on E-Plate 16 of the RTCA DP instrument. After 24 hours, cells 
were irradiated at a single dose of 8 Gy. (A) Cell proliferation was continuously monitored for 63 hours. (B) Cell proliferation at three 
time points (36 h, 48 h and 60 h). The assay was performed in triplicate. Bars indicate standard deviation, *p < 0.05 and **p < 0.01 by 
Student’s t-test.
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In terms of quantity, levels of tissue 
ebv-miR-BART7 were significantly 
higher in primary cancer tissues as 
compared with the corresponding 
control tissues (Figure 1A). When 
we compared the ebv-miR-BART7 
expression level between primary 
NPC, recurrent NPC and normal 
nasopharyngeal tissues obtained 
from different individuals, the ebv-
miR-BART7 expression level was 
significantly higher in primary NPC 
tissues (p < 0.001, Mann–Whitney 
U test) and recurrent NPC tissues (p 
< 0.001, Mann–Whitney U test). In 
addition, primary NPC tissues had a 
significantly higher expression level 
of ebv-miR-BART7 as compared with 
the recurrent NPC tissues (p < 0.001, 
Mann–Whitney U test); for the recur-
rent NPC cases, paired normal tissues 
of the same individuals were available 
(Figure 1B). When we compared the 
recurrent NPC tissues with the paired 
normal tissues, significantly higher 
levels of tissue ebv-miR-BART7 were 
observed (p = 0.005, Wilcoxon signed-
rank test). In addition, we noticed that 
the normal tissues of recurrent NPC 
patients had a significantly higher 
level of ebv-miR-BART7 (Figure 1B) in 
comparison with the normal tissues 
obtained from the normal individuals 
(Figure 1A) (p < 0.001, Mann–Whitney 
U test). 
Expression of ebv-miR-BART7 
reduced the colony formation ability 
aft er radiation treatment
Without radiation treatment, ectopic 
expression of ebv-miR-BART7 in 
HONE1 cells had no significant effects 
on the colony formation ability. 
After radiation treatment, a dose-
dependent decrease in the number 
of colonies was observed. Significant 
reduction in the number of HONE1 
colonies was observed when the cells 
were exposed to 2–8 Gy radiation 
(Figure 2).
Decreased proliferation rate in ebv-
miR-BART7-expressing cells aft er 
radiation treatment
After radiation treatment, the 
proliferation of ebv-miR-BART7-
expressing HONE1 cells was moni-
tored continuously (Figure 3). At low 
ebv-miR-BART7 concentration (0.75 
nM), no significant change in the 
proliferation rate was observed after 
radiation treatment. In comparison, 
when the ectopic expression level 
was increased from 0.75 nM to 1.5 
and 3 nM, significant reduction in 
cell proliferation rate was observed 
when the cells were irradiated at a 
single dose of 8 Gy. 
Expression of ebv-miR-BART7 
 promoted radiation-induced 
 apoptosis in HONE1 cells
As shown in Figure 4, radiation 
treatment induced apoptosis in 
both control and ebv-miR-BART7-
expressing cells in a dose-dependent 
manner. Without radiation treatment, 
ectopic ebv-miR-BART7 expression 
did not affect the apoptosis rate in 
the HONE1 cells. Significant increase 
in the apoptotic population was 
observed when the ebv-miR-BART7-
expressing cells were exposed to 
radiation at 2–8 Gy. 
Ectopic ebv-miR-BART7 expression 
enhanced the formation of γH2AX 
foci in HONE1 cells upon irradiation 
treatment
To assess the effects of ebv-miR-
BART7 on radiation-induced DNA 
double-strand break, we detected the 
formation of γH2AX foci in HONE1 
cells after irradiation treatment. 
Irradiation treatment resulted in the 
formation of γH2AX foci in a dose-
dependent manner in both control 
and ebv-miR-BART7-expressing cells 
(Figure 5). Forced ebv-miR-BART7 
Figure 4: Ebv-miR-BART7 promoted irradiation-induced apoptosis in HONE1 cells. 
HONE1 cells were transfected with 3 nM ebv-miR-BART7 mimics or the negative con-
trol. After 24 hours, cells were irradiated at a single dose of 2, 4, 6 or 8 Gy. The irradi-
ated cells were stained by FITC-labelled Annexin V and analysed by flow cytometry. (A) 
Representative pictures showing apoptosis of HONE1 cells after radiation treatment. (B) 
Statistical analysis of apoptosis of HONE1 cells after radiation treatment. The assay was 
performed in four-replicate. Bars indicate standard deviation, *p < 0.05 and **p < 0.01 
by Student’s t-test.
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expression elevated the number of 
γH2AX foci by 42.4%, 55.2%, 25.0% 
and 12.0% upon radiation treatment 
at the dose of 2, 4, 6 and 8 Gy, respec-
tively (Figure 5).
Ectopic ebv-miR-BART7 expression 
promotes radiation-induced au-
tophagy in HONE1 cells
Prominent changes in cell morphology 
were observed when the HONE1 cells 
were exposed to radiation stress. 
Increase in the number of cells 
entering autophagy was observed 
when the radiation dose increased 
from 2 Gy to 8 Gy. In the control 
sample, cells filled with AVO were 
detected when the cells were exposed 
to radiation of 6 Gy or above. In ebv-
miR-BART7-expressing cells, the AVO-
filled cells appeared when the cells 
were exposed to 4 Gy (Figure 6). 
ebv-miR-BART7 enhanced radiosen-
sitivity of HONE1 cells in an in vivo 
zebrafi sh model
We used a zebrafish model to evaluate 
the effects of ebv-miR-BART7 expres-
sion on radiosensitivity of HONE1 cells 
in vivo. Forced expression of ebv-miR-
BART7 resulted in the reduction of 
the fluorescence signal after radiation 
treatment (Figure 7). At 2 Gy and 6 Gy, 
the fluorescence signal of ebv-miR-
BART7-expressing cells was reduced 
by 30.3% and 38.9%, respectively, in 
comparison with the control. At 4 Gy, 
forced expression of ebv-miR-BART7 
significantly reduced the fluorescence 
signal of HONE1 cells by 86.9% in the 
zebrafish model (Figure 7).
Discussion
The EBV genome contains 2 major 
clusters (BHRF1 and BART clus-
ters) coding for 25 precursors and 
44 mature viral-encoded miRNAs. 
In our preliminary study, we identi-
fied that ebv-miR-BART7 is a potent 
oncogene in NPC cells. Ebv-miR-
BART7 is a viral-encoded miRNA 
that is highly expressed in NPC cells 
infected with EBV latently. Mature 
ebv-miR-BART7 (MIMAT0003416) is 
a single-stranded molecule containing 
22 nucleotides (5’-CAUCAUAGUC-
CAGUGUCCAGGG-3’) with unknown 
functions. Ebv-miR-BART7 has gained 
much attention as its expression level 
is relatively high in comparison with 
other EBV-encoded miRNAs in EBV-
infected cell lines8. In comparison 
with other BART members, expres-
sion levels of ebv-miR-BART7 in the 
host cell increases exponentially after 
EBV infection8. In 2010, Chen et al. 
observed that ebv-miR-BART7 expres-
sion was significantly upregulated 
in human NPC tissues18. Later, it was 
reported that circulating ebv-miR-
BART7 was detected in the peripheral 
blood of NPC patients10. In this study, 
we first measured the expression of 
ebv-miR-BART7 in nasopharyngeal 
tissues. We observed that ebv-miR-
BART7 could be detected in all the 
tissue samples and was differentially 
expressed. Both primary and recur-
rent NPC tissues had significantly high 
ebv-miR-BART7 levels in comparison 
with the normal controls. The high 
expression level of ebv-miR-BART7 
in primary and recurrent NPC tissues 
suggested that ebv-miR-BART7 plays 
an important role in the development 
of the disease. 
Figure 5: Ebv-miR-BART7 increased the formation of γH2AX foci in HONE1 cells upon 
irradiation treatment. HONE1 cells were transfected with 3 nM ebv-miR-BART7 mimics 
or negative control siRNA. Twenty-four hours after transfection, the cells were irradiated 
at a single dose of 2, 4, 6 or 8 Gy. The irradiated cells were fixed and incubated with rab-
bit polyclonal anti-γH2AX antibodies. DAPI and Alexa Fluor® 635 phalloidin were used 
to stain the nucleus and F-actin. (A) Representative pictures showing the formation of 
γH2AX foci in HONE1 cells after radiation treatment. (B) Statistical analysis of the num-
ber of γH2AX foci in cells. Bars indicate standard deviation, n = 50, *p < 0.05 and **p < 
0.01 by Student’s t-test.
Original research study
Page 7 of 8
Co
m
pe
Ɵ n
g 
in
te
re
st
s:
 n
on
e 
de
cl
ar
ed
. C
on
fl i
ct
 o
f I
nt
er
es
ts
: n
on
e 
de
cl
ar
ed
.
A
ll 
au
th
or
s 
co
nt
rib
ut
ed
 to
 th
e 
co
nc
ep
Ɵ o
n,
 d
es
ig
n,
 a
nd
 p
re
pa
ra
Ɵ o
n 
of
 th
e 
m
an
us
cr
ip
t,
 a
s 
w
el
l a
s 
re
ad
 a
nd
 a
pp
ro
ve
d 
th
e 
fi n
al
 m
an
us
cr
ip
t.
A
ll 
au
th
or
s 
ab
id
e 
by
 th
e 
A
ss
oc
ia
Ɵ o
n 
fo
r M
ed
ic
al
 E
th
ic
s 
(A
M
E)
 e
th
ic
al
 ru
le
s 
of
 d
is
cl
os
ur
e.
Licensee OA Publishing London 2013. Creative Commons Attribution Licence (CC-BY)
FĔė ĈĎęĆęĎĔē ĕĚėĕĔĘĊĘ: Chan YWJ, Gao W, Li ZHJ, Ho WK, Wong TS. Expression of Epstein-Barr virus-encoded BamH1-a 
 rightward transcript 7 microRNA in nasopharyngeal carcinoma cells modulates the responsiveness to irradiation  treatment. 
Head Neck Oncol. 2013 Mar 06;5(3):34.
Figure 6: Representative pictures showed that ebv-miR-BART7 elevated radiation-induced autophagy in HONE1 cells. HONE1 cells were 
transfected with 3 nM ebv-miR-BART7 mimics or the negative control. Twenty-four hours after transfection, the cells were irradiated at a single 
dose of 2, 4, 6 or 8 Gy. The irradiated cells were stained with AO. Arrows indicate the staining of AVOs.
Figure 7: Ebv-miR-BART7 enhanced radiosensitivity of HONE1 cells in an in vivo zebrafish model. HONE1 cells transfected with 
ebv-miR-BART7 mimics or negative control siRNA were stained with DiO and microinjected into 48-hpf zebrafish embryos. Zebrafish 
embryos were subjected to irradiation 24 hours after microinjection. The fluorescence signal was determined before and 4 days af-
ter irradiation treatment. The fluorescence signal of HONE1 cells transfected with ebv-miR-BART7 mimics was normalised to that of 
HONE1 cells transfected with the negative control. (A) Representative pictures showing fluorescence signal of HONE1 cells in zebrafish 
embryos before and after irradiation treatment. (B) Statistical analysis of the relative fluorescence signal of HONE1 cells in zebrafish 
embryos upon irradiation treatment. Bars indicate standard deviation, n = 5, **p < 0.01 by Student’s t-test.
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When we compared primary and 
recurrent NPC alone, we noticed 
that patients with recurrent NPC 
had a notably lower ebv-miR-BART7 
level. Early recurrent NPC patients 
are usually treated with surgery, as 
a second course of radiation may 
damage the brainstem, the optic 
apparatus and the temporal lobes 
adjacent to the tumours, resulting in 
long-term side effects19. More impor-
tantly, the recurrent NPC tissue may 
have developed radiation resistance 
during the first course of radiation 
or may have developed from the 
intrinsically radiation-resistant clone 
which escaped initial radiotherapy20. 
In general, patients with recurrent 
disease at the nasopharynx and/or 
neck nodes after radiotherapy are 
considered radioresistant patients6. 
If high ebv-miR-BART7 is a contrib-
uting factor to the high radiation 
sensitivity of primary NPC, cancer 
cells with low ebv-miR-BART7 might 
have the chance to escape from the 
first radiation treatment, leading to 
the development of recurrent disease. 
As the recurrent NPC patients did not 
receive radiation treatment again, 
we could not validate the suggested 
association on radiation sensitivity/
resistance with the use of tissue 
samples. To examine the response 
of the NPC cells to ionising radia-
tion, we therefore generated the ebv-
miR-BART7-expressing model with 
the use of a NPC cell line. Based on 
these observations, we suggest that 
the expression of ebv-miR-BART7 is 
associated with primary NPC and is 
linked to the responsiveness of NPC 
cells to irradiation treatment. Further 
studies are warranted to confirm 
whether ebv-miR-BART7 could be 
used as a therapeutic biomarker to 
monitor the outcome of radiation-
treated NPC patients. 
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